Patent · US Active

Tuberculosis compositions and methods of using the same

US11787842B2 · kind B2 · utility

0Cited by

4References

14Claims

0Family size

Assignee

International AIDS Vaccine Initiative, Inc. · US

Inventors

Ravi P. Anantha · Gaithersburg, US
Nathalie Cadieux · New York, US
Thomas G. Evans · New York, US
Michele Stone · New York, US
Barry Walker · New York, US

Key dates

Filing date	Apr 21, 2021
Grant date	Oct 17, 2023
Priority date	—
Expiry date	Apr 21, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.